| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 06/20/2007 | CN1982329A Biologically active peptide comprising tyrosyl-seryl-valine (YSV) and use thereof |
| 06/20/2007 | CN1321688C Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 06/20/2007 | CN1321682C New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 06/19/2007 | US7232924 Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| 06/19/2007 | US7232881 Peptide containing Ser-Ser-Ser-Arg |
| 06/19/2007 | US7232818 Compounds for enzyme inhibition |
| 06/19/2007 | US7232817 α- and β-amino acid hydroxyethlamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 06/19/2007 | US7232804 Use of KPV tripeptide for dermatological disorders |
| 06/19/2007 | US7232803 Molecule comprising backbone of 2-35 non-hydrogen atoms in length, having covalently attached bulky lipoophilic groups and having more cationic than anionic moiety in manufacturing medicament for destabilising microbial cell membranes |
| 06/19/2007 | US7232802 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 06/19/2007 | US7232801 Administering a peptide whose sequence coincide with regions of the IL-16 receptor (CD4) to interfere with or prevent binding to an IL-16 receptor; treating asthma, arthritis, IBD, Systemic Lupus, multiple sclerosis, Graves opthalmopathy, atopic rhinitis, atopic dermatitis and bullous pemphigoid |
| 06/19/2007 | US7232559 Diagnostic agents for pancreatic exocrine function |
| 06/19/2007 | CA2189690C Novel active peptide and its preparation |
| 06/14/2007 | WO2007066617A1 Condensation reaction by metal catalyst |
| 06/14/2007 | WO2007065691A2 Small peptidic and peptido-mimetic affinity ligands for factor viii and factor viii-like proteins |
| 06/14/2007 | WO2007014253A3 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
| 06/14/2007 | WO2006127702A3 Analogs of glycyl-prolyl-glutamate |
| 06/14/2007 | US20070135386 Novel Compounds and Compositions as Cathepsin Inhibitors |
| 06/14/2007 | US20070135356 Gamma aminobutyric acid antagonist; naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative disorders; analgesics; drug withdrawal |
| 06/14/2007 | US20070135355 Functionalized diphenolics and absorbable polymers therefrom |
| 06/14/2007 | US20070135353 Crystalline n-formyl hydroxylamine compounds |
| 06/14/2007 | US20070135334 Peptides and methods using same for diagnosing and treating amyloid-associated diseases |
| 06/14/2007 | US20070134221 Stabilizing peptides |
| 06/14/2007 | CA2632714A1 Small peptidic and peptido-mimetic affinity ligands for factor viii and factor viii-like proteins |
| 06/14/2007 | CA2630500A1 Matrix-controlled transdermal system comprising salts of ace inhibitor dicarboxylic acids |
| 06/13/2007 | EP1794182A2 Compounds that modulate trh actions and inhibit the trh-degrading enzyme |
| 06/13/2007 | EP1793843A1 Macrocyclic sh2 domain binding inhibitors |
| 06/13/2007 | EP1625150B9 Tripeptides and derivatives thereof for cosmetic application in order to improve skin structure |
| 06/13/2007 | EP1176870B1 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/13/2007 | EP0742902B2 A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen |
| 06/13/2007 | CN1978462A Imidazoline modified amino acid, and its synthesizing method and use for polypeptide marking |
| 06/13/2007 | CN1978454A Modular peptide-based reagent |
| 06/13/2007 | CN1321130C Biologic preparation method of cyclic dipeptide analogue compound and uses thereof |
| 06/13/2007 | CN1321129C Inhibitors of caspases |
| 06/12/2007 | US7230077 Polypeptide encoded by a nucleic acid underexpressed in melanoma |
| 06/12/2007 | US7230074 Inhibitors of dipeptidyl-aminopeptidase type IV |
| 06/12/2007 | US7229970 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/12/2007 | US7229960 Administering a non-phosphorylated tripeptides |
| 06/07/2007 | WO2007064997A2 Compounds and methods for inhibiting apoptosis |
| 06/07/2007 | WO2004063214A3 Antibodies that specifically recognize sumo-conjugated proteins |
| 06/07/2007 | WO2000044335A3 Uridyl peptide antibiotic (upa) derivatives, their synthesis and use |
| 06/07/2007 | US20070129394 Rapamycin conjugated to peptides of up to 10 amino acid units through a carbamate linkage at position 42; coated stents; restenosis, cancer, autoimmune, transplant rejection |
| 06/07/2007 | US20070129313 Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1) |
| 06/07/2007 | US20070129311 Compounds comprising two human GlxI inhibitors covalently linked via a diacid where each of the inhibitors may be the same or different and is an S-substituted glutathione or a prodrug thereof having a gamma-glutamyl amino group; length >50 Angstroms; antitumor, -carcinogenic, -proliferative agents |
| 06/07/2007 | US20070129290 Metabolite derivatives of the HDAC inhibitor FK228 |
| 06/07/2007 | US20070129289 Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them |
| 06/07/2007 | US20070129288 Antibacterial amide macrocycles |
| 06/07/2007 | CA2631731A1 Compounds and methods for inhibiting apoptosis |
| 06/06/2007 | EP1792910A2 Effectors of dipeptidyl peptidase IV for topical use |
| 06/06/2007 | EP1791969A2 A method of treating cancer |
| 06/06/2007 | EP1791856A1 Alpha-keto carbonyl calpain inhibitors |
| 06/06/2007 | CN1976947A Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives |
| 06/06/2007 | CN1976945A Isopeptide gap junction modulators |
| 06/06/2007 | CN1974596A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 06/06/2007 | CN1974554A Cyclin imide peptidyl metalloprotease inhibitor and its application |
| 06/06/2007 | CN1319987C Gamma-secretase inhibitors |
| 06/05/2007 | US7226991 inhibiting SH2 domain binding with a phosphoprotein; to inhibit proliferation of tumor cells; for inhibiting the growth of human breast cancer cells |
| 06/05/2007 | US7226935 Hypoglycemic agent |
| 06/05/2007 | US7226929 drugs such as 6 -Chloro-N-{(3S)-1-[(1S)-1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide, used as antithrombotic agents |
| 06/05/2007 | US7226921 An enzyme inhibitor of cysteine proteases, a morpholine-4-carboxyamide 1,3,4-oxadiazole derivatives; for treating arthritis, muscular dystrophy, inflammation, tumor, glomerulonephritis, malaria, periodontal disease |
| 06/05/2007 | US7226906 Analogs which are topically active but systemically less active, providing therapy to subjects without the risk of systemic side effects |
| 06/05/2007 | US7226904 Agents and methods for promoting bone growth |
| 06/05/2007 | US7226770 For use in detergents and in baking |
| 06/05/2007 | US7226591 Nucleotide sequences coding protein for use in the prevention and treatment of pancreatitis |
| 05/31/2007 | WO2007061939A2 Metabolite derivatives of the hdac inhibitor fk228 |
| 05/31/2007 | WO2007060886A1 Therapeutic agent for neurodegenerative disease |
| 05/31/2007 | WO2007060524A1 Compounds for the inhibition of apoptosis |
| 05/31/2007 | WO2007059908A1 Novel cyclic iminopeptide derivatives and a process for preparing cyclic iminopeptide derivatives |
| 05/31/2007 | WO2007025219A3 Nogo receptor polypeptides and polypeptide fragments and uses thereof |
| 05/31/2007 | WO2007008657A3 Hepatitis c virus inhibitors |
| 05/31/2007 | WO2006102098A3 Immunogens for vaccines against antigenically variable pathogens and diseases |
| 05/31/2007 | WO2005117940A3 Cell death modulation via antagonists of fasl and fas activation |
| 05/31/2007 | US20070123709 Beta-amino acids |
| 05/31/2007 | US20070123696 G-csf conjugates |
| 05/31/2007 | US20070123581 Coupling, hydrogenation, catalysis; reacting benzyl indole-2-carboxylate with acid and alanine compound; amidation, salt formation |
| 05/31/2007 | US20070123469 Cyclic and linear oligopeptides; capable of increasing gap junction conductance; lack the proarrhythmic side effects; use as drug to also treat eye disorders, cancer, and gastrointestinal disorders among others |
| 05/31/2007 | US20070123468 Prodrugs of active agents |
| 05/31/2007 | US20070123450 oxidized glutathione-based compound having a stabilized disulfide bond and either platinum and palladium |
| 05/31/2007 | US20070122451 Biogically non-degradable peptides, angiostensin converting enzyme inhibitor, drug and functional food |
| 05/31/2007 | CA2630926A1 Compounds for the inhibition of apoptosis |
| 05/31/2007 | CA2630216A1 Metabolite derivatives of the hdac inhibitor fk228 |
| 05/30/2007 | EP1790655A2 Biologically active peptides |
| 05/30/2007 | EP1429763B1 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 05/30/2007 | EP1177168B1 Caspase inhibitors and the use thereof |
| 05/30/2007 | EP0914605B1 Molecular model for vla-4 inhibitors |
| 05/30/2007 | CN1973053A Novel anti-IL 13 antibodies and uses thereof |
| 05/30/2007 | CN1973042A Process for producing dipeptides |
| 05/30/2007 | CN1973037A Process for producing dipeptides or dipeptide derivatives |
| 05/30/2007 | CN1972960A Processes for preparing eptifibatide |
| 05/30/2007 | CN1972956A Novel compounds as inhibitors of hepatitis c virus NS3 serine protease |
| 05/30/2007 | CN1970078A Peptides and related molecules that bind to tall-1 |
| 05/30/2007 | CN1970077A Peptides and related molecules that bind to tall-1 |
| 05/30/2007 | CN1318444C Method for producing carnosine |
| 05/30/2007 | CN1318426C Novel cantharidimide and norcantharidimide derivant and its application in medicine |
| 05/30/2007 | CN1318084C Neuroprotective peptides |
| 05/29/2007 | US7223888 Mu opioid receptor ligands: methods of use and synthesis |
| 05/29/2007 | US7223872 Reaction of benzyl (2S)-2,3,4,5,6,7-hexahydro-1H-indole-2-carboxylate with triethylamine and then (2S)-2-[(tert-butoxycarbonyl)amino]propionyl chloride and reaction of product with ethyl 2-oxopentanoate and hydrogenation using platinum on carbon catalyst |
| 05/29/2007 | US7223837 Anticancer prodrugs, enhance enzymatic activation rates |
| 05/29/2007 | US7223835 Cyclic peptide mimetic for treating cancer; anticarcinogenic agents |
| 05/29/2007 | US7223833 Peptide nucleic acid conjugates |